Effect of Gender and Age on the Pharmacokinetics of Repinotan

被引：0
|
作者：
Roland Heinig
Pavur Sundaresan
Anita Shah
Michael Boettcher
机构：
[1] Bayer HealthCare AG,Institute of Clinical Pharmacology
[2] Bayer Pharmaceuticals Corporation,Department of Clinical Pharmacology
[3] Bayer Pharmaceuticals Corporation,Preclinical Drug Development
来源：
Clinical Drug Investigation | 2005年 / 25卷
关键词：
Dextromethorphan; Extensive Metaboliser; Debrisoquine; Metabolic Ratio; Sparteine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: Repinotan hydrochloride (repinotan) is a selective, high-affinity, full serotonin receptor agonist at the 5-HT1a subtype that is undergoing clinical development in acute stroke. To investigate whether gender is an important covariable for repinotan pharmacokinetics, two studies were performed in subjects of different age and gender who had been phenotyped as extensive metabolisers for cytochrome P450 (CYP)2D6 using dextromethorphan as model substrate.
引用
收藏
页码：125 / 134
页数：9
相关论文
共 50 条
  • [1] The effect of gender and age on pharmacokinetics of repinotan
    Heinig, R
    Sundarcsan, P
    Shah, A
    STROKE, 2004, 35 (06) : E287 - E287
  • [2] Effect of gender and age on the pharmacokinetics of repinotan
    Heinig, R
    Sundaresan, P
    Shah, A
    Boettcher, M
    CLINICAL DRUG INVESTIGATION, 2005, 25 (02) : 125 - 134
  • [3] Effect of age and gender on the pharmacokinetics of eprosartan
    Tenero, DM
    Martin, DE
    Miller, AK
    Ilson, B
    Boike, SC
    Zariffa, N
    Jorkasky, DK
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (03) : 267 - 270
  • [4] Effect of age and gender on the pharmacokinetics of grepafloxacin
    Efthymiopoulos, C
    Bramer, SL
    Maroli, A
    CLINICAL PHARMACOKINETICS, 1997, 33 (Suppl 1) : 9 - 17
  • [5] Effect of Age and Gender on the Pharmacokinetics of Grepafloxacin
    Constantin Efthymiopoulos
    Steven L. Bramer
    Allan Maroli
    Clinical Pharmacokinetics, 1997, 33 : 9 - 17
  • [6] Effect of age and gender on the pharmacokinetics of eslicarbazepine acetate
    Soares-Da-Silva, P
    Almeida, L
    Falcao, A
    Maia, J
    EPILEPSIA, 2005, 46 : 216 - 217
  • [7] Effect of age and gender on pharmacokinetics of atorvastatin in humans
    Gibson, DM
    Bron, NJ
    Richens, A
    Hounslow, NJ
    Sedman, AJ
    Whitfield, LR
    JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 36 (03): : 242 - 246
  • [8] Effect of age and gender on the pharmacokinetics and pharmacodynamics of bilastine
    Roupe, Kathryn
    Sologuren, Ander
    Crean, Christopher
    Valiente, Roman
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (09): : 1198 - 1198
  • [9] EFFECT OF AGE AND GENDER ON TIRILAZAD PHARMACOKINETICS IN HUMANS
    HULST, LK
    FLEISHAKER, JC
    PETERS, GR
    HARRY, JD
    WRIGHT, DM
    WARD, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (04) : 378 - 384
  • [10] Effect of age and gender on the pharmacokinetics of solifenacin.
    Smulders, R
    Taekema, M
    Krauwinkel, W
    Raghoebar, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P73 - P73
12345